{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:46Z","timestamp":1792643926091,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05212-5","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:55:32Z","timestamp":1784955332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between prediabetes and nephropathy: a comprehensive systematic review and meta-analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Raheleh","family":"Karimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setayesh","family":"Sindarreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Maracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"5212_CR1","doi-asserted-by":"crossref","unstructured":"Niazi AK, Shafique K, Schwartz PEH. Primary prevention of diabetes mellitus type 2. BIDE\u2019s diabetes desk book. Elsevier; 2024. pp. 427\u201345.","DOI":"10.1016\/B978-0-443-22106-4.00001-2"},{"issue":"3","key":"5212_CR2","doi-asserted-by":"publisher","first-page":"e2004","DOI":"10.1002\/hsr2.2004","volume":"7","author":"MJ Hossain","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep. 2024;7(3):e2004.","journal-title":"Health Sci Rep"},{"key":"5212_CR3","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.deman.2024.100239","volume":"17","author":"TB Vuong","year":"2025","unstructured":"Vuong TB, Tran TM, Tran NQ. High prevalence of prediabetes and type 2 diabetes, and identification of associated factors, in high-risk adults in Vietnam: A cross-sectional study. Diabetes Epidemiol Manage. 2025;17:100239.","journal-title":"Diabetes Epidemiol Manage"},{"issue":"Supplement1","key":"5212_CR4","first-page":"S15","volume":"44","author":"AD Association","year":"2020","unstructured":"Association AD. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142021. Diabetes Care. 2020;44(Supplement1):S15\u201333.","journal-title":"Diabetes Care"},{"issue":"5","key":"5212_CR5","first-page":"615","volume":"34","author":"AK Khetan","year":"2018","unstructured":"Khetan AK, Rajagopalan S, Prediabetes. Can J Cardiol. 2018;34(5):615\u201323.","journal-title":"Can J Cardiol"},{"issue":"1","key":"5212_CR6","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1038\/s41598-019-39221-2","volume":"9","author":"R Wang","year":"2019","unstructured":"Wang R, Zhang P, Li Z, Lv X, Cai H, Gao C, et al. The prevalence of pre-diabetes and diabetes and their associated factors in Northeast China: a cross-sectional study. Sci Rep. 2019;9(1):2513.","journal-title":"Sci Rep"},{"key":"5212_CR7","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"5212_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1753-0407.13291","volume":"14","author":"C Han","year":"2022","unstructured":"Han C, Song Q, Ren Y, Chen X, Jiang X, Hu D. Global prevalence of prediabetes in children and adolescents: A systematic review and meta-analysis. J Diabetes. 2022;14(7):434\u201341.","journal-title":"J Diabetes"},{"key":"5212_CR9","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00125-010-1794-9","volume":"53","author":"G Jerums","year":"2010","unstructured":"Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical significance of hyperfiltration in diabetes. Diabetologia. 2010;53:2093\u2013104.","journal-title":"Diabetologia"},{"issue":"10","key":"5212_CR10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2337\/dc11-2189","volume":"35","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Porrini EL, Gaspari F, Motterlini N, Cannata A, Carrara F, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care. 2012;35(10):2061\u20138.","journal-title":"Diabetes Care"},{"issue":"19","key":"5212_CR11","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa042167","volume":"351","author":"P Ruggenenti","year":"2004","unstructured":"Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351(19):1941\u201351.","journal-title":"N Engl J Med"},{"issue":"11","key":"5212_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.7326\/0003-4819-139-11-200312020-00008","volume":"139","author":"K Wachtell","year":"2003","unstructured":"Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139(11):901\u20136.","journal-title":"Ann Intern Med"},{"key":"5212_CR13","doi-asserted-by":"publisher","first-page":"1294819","DOI":"10.3389\/fendo.2024.1294819","volume":"15","author":"X An","year":"2024","unstructured":"An X, Zhang Y, Sun W, Kang X, Ji H, Sun Y, et al. Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: A systematic review and meta-analysis based on high-quality clinical studies. Front Endocrinol. 2024;15:1294819.","journal-title":"Front Endocrinol"},{"issue":"6","key":"5212_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1053\/j.ajkd.2015.10.025","volume":"67","author":"T Melsom","year":"2016","unstructured":"Melsom T, Schei J, Stefansson VTN, Solbu MD, Jenssen TG, Mathisen UD, et al. Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study. Am J Kidney Dis. 2016;67(6):841\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5212_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","volume":"4","author":"S Ligthart","year":"2016","unstructured":"Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. lancet Diabetes Endocrinol. 2016;4(1):44\u201351.","journal-title":"lancet Diabetes Endocrinol"},{"issue":"4","key":"5212_CR16","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314.","journal-title":"Kidney Int"},{"key":"5212_CR17","doi-asserted-by":"crossref","unstructured":"Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Diabetic nephropathy: methods and protocols. 2019;3\u20137.","DOI":"10.1007\/978-1-4939-9841-8_1"},{"issue":"3","key":"5212_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2337\/cd21-0090","volume":"40","author":"KN Davis","year":"2022","unstructured":"Davis KN, Hines AE, Schaefer MC, Naseman KW. Protecting the kidneys: Update on therapies to treat diabetic nephropathy. Clin Diabetes. 2022;40(3):305\u201311.","journal-title":"Clin Diabetes"},{"issue":"12","key":"5212_CR19","first-page":"751","volume":"99","author":"K McGrath","year":"2019","unstructured":"McGrath K, Edi R. Diabetic kidney disease: diagnosis, treatment, and prevention. Am Family Phys. 2019;99(12):751\u20139.","journal-title":"Am Family Phys"},{"key":"5212_CR20","unstructured":"Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372."},{"issue":"6","key":"5212_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","volume":"149","author":"BL Neuen","year":"2024","unstructured":"Neuen BL, Heerspink HJ, Vart P, Claggett BL, Fletcher RA, Arnott C, et al. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation. 2024;149(6):450\u201362.","journal-title":"Circulation"},{"issue":"12","key":"5212_CR22","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022;45(12):3075\u201390.","journal-title":"Diabetes Care"},{"issue":"1","key":"5212_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"JL Gross","year":"2005","unstructured":"Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164\u201376.","journal-title":"Diabetes Care"},{"issue":"4","key":"5212_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2215\/CJN.07891109","volume":"5","author":"LC Plantinga","year":"2010","unstructured":"Plantinga LC, Crews DC, Coresh J, Miller ER III, Saran R, Yee J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010;5(4):673\u201382.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5212_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5527\/wjn.v4.i1.57","volume":"4","author":"S Lopez-Giacoman","year":"2015","unstructured":"Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015;4(1):57.","journal-title":"World J Nephrol"},{"issue":"9","key":"5212_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"4","key":"5212_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247\u201354.","journal-title":"Ann Intern Med"},{"issue":"3","key":"5212_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5662\/wjm.v7.i3.73","volume":"7","author":"A Alaini","year":"2017","unstructured":"Alaini A, Malhotra D, Rondon-Berrios H, Argyropoulos CP, Khitan ZJ, Raj DS, et al. Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate. World J Methodol. 2017;7(3):73.","journal-title":"World J Methodol"},{"issue":"3","key":"5212_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/bios15030145","volume":"15","author":"A Thiengsusuk","year":"2025","unstructured":"Thiengsusuk A, Youngvises N, Pochairach R, Taha RO, Sirisabhabhorn K, Muhamad N, et al. Urinary Albumin-to-Creatinine Ratio (uACR) Point-of-Care (POC) Device with Seamless Data Transmission for Monitoring the Progression of Chronic Kidney Disease. Biosensors. 2025;15(3):145.","journal-title":"Biosensors"},{"issue":"13","key":"5212_CR30","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294\u2013304.","journal-title":"JAMA"},{"key":"5212_CR31","doi-asserted-by":"publisher","first-page":"675071","DOI":"10.3389\/frma.2021.675071","volume":"6","author":"M Drukker","year":"2021","unstructured":"Drukker M, Weltens I, van Hooijdonk CF, Vandenberk E, Bak M. Development of a methodological quality criteria list for observational studies: the observational study quality evaluation. Front Res metrics analytics. 2021;6:675071.","journal-title":"Front Res metrics analytics"},{"issue":"2","key":"5212_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random\u2010effects models for meta\u2010analysis. Res synthesis methods. 2010;1(2):97\u2013111.","journal-title":"Res synthesis methods"},{"issue":"5","key":"5212_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","volume":"44","author":"AK Bidani","year":"2004","unstructured":"Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595\u2013601.","journal-title":"Hypertension"},{"issue":"24","key":"5212_CR34","doi-asserted-by":"publisher","first-page":"e7169","DOI":"10.1097\/MD.0000000000007169","volume":"96","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhong B, Li Y, Qin X, Wang B, Xu X, et al. Relationship of diabetes with renal dysfunction in hypertensive adults. Med (Baltim). 2017;96(24):e7169.","journal-title":"Med (Baltim)"},{"issue":"10","key":"5212_CR35","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3390\/nu13103341","volume":"13","author":"B-H Khor","year":"2021","unstructured":"Khor B-H, Tallman DA, Karupaiah T, Khosla P, Chan M, Kopple JD. Nutritional adequacy of animal-based and plant-based Asian diets for chronic kidney disease patients: a modeling study. Nutrients. 2021;13(10):3341.","journal-title":"Nutrients"},{"key":"5212_CR36","doi-asserted-by":"publisher","first-page":"965545","DOI":"10.3389\/fendo.2022.965545","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Huang C, Liu Y, Han Y, Hu H. Association of estimated glomerular filtration rate and incident pre-diabetes: A secondary 5-year longitudinal cohort study in Chinese people. Front Endocrinol. 2022;13:965545.","journal-title":"Front Endocrinol"},{"issue":"9","key":"5212_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"5","author":"ASSL Levey","year":"2009","unstructured":"Levey ASSL, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;5(9):604\u201312. PMID: 19414839.","journal-title":"Ann Intern Med"},{"issue":"12","key":"5212_CR38","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/dme.13113","volume":"33","author":"J Echouffo-Tcheugui","year":"2016","unstructured":"Echouffo-Tcheugui J, Narayan K, Weisman D, Golden SH, Jaar B. Association between prediabetes and risk of chronic kidney disease: a systematic review and meta\u2010analysis. Diabet Med. 2016;33(12):1615\u201324.","journal-title":"Diabet Med"},{"issue":"11","key":"5212_CR39","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.7150\/ijms.46477","volume":"17","author":"C Chen","year":"2020","unstructured":"Chen C, Liu G, Yu X, Yu Y, Liu G. Association between prediabetes and renal dysfunction from a community-based prospective study. Int J Med Sci. 2020;17(11):1515.","journal-title":"Int J Med Sci"},{"issue":"1","key":"5212_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.ajkd.2007.09.014","volume":"51","author":"J Lucove","year":"2008","unstructured":"Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51(1):21\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5212_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/dmrr.1058","volume":"26","author":"H Watanabe","year":"2010","unstructured":"Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diab\/Metab Res Rev. 2010;26(1):26\u201332.","journal-title":"Diab\/Metab Res Rev"},{"key":"5212_CR42","doi-asserted-by":"crossref","unstructured":"Baydar \u0130, \u015eaniba\u015f AV, Binici DN. Although diabetes is not obvious, its complications may be obvious, frequency of nephropathy in prediabetic patients. J Contemp Med. 14(1):21\u20134.","DOI":"10.16899\/jcm.1388853"},{"issue":"1","key":"5212_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1479164113514239","volume":"11","author":"FY Xing","year":"2014","unstructured":"Xing FY, Neeland IJ, Gore MO, Ayers CR, Paixao AR, Turer AT, et al. Association of prediabetes by fasting glucose and\/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study. Diabetes Vascular Disease Res. 2014;11(1):11\u20138.","journal-title":"Diabetes Vascular Disease Res"},{"issue":"5","key":"5212_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ypmed.2013.08.002","volume":"57","author":"B Sch\u00f6ttker","year":"2013","unstructured":"Sch\u00f6ttker B, Brenner H, Koenig W, M\u00fcller H, Rothenbacher D. Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany. Prev Med. 2013;57(5):596\u2013600.","journal-title":"Prev Med"},{"issue":"4","key":"5212_CR45","doi-asserted-by":"publisher","first-page":"e1772","DOI":"10.1210\/clinem\/dgaa017","volume":"105","author":"JS Neves","year":"2020","unstructured":"Neves JS, Correa S, Baeta Baptista R, Bigotte Vieira M, Waikar SS, Mc Causland FR. Association of prediabetes with CKD progression and adverse cardiovascular outcomes: an analysis of the CRIC study. J Clin Endocrinol Metabolism. 2020;105(4):e1772\u201380.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"5212_CR46","doi-asserted-by":"publisher","first-page":"7373","DOI":"10.1038\/s41598-022-11392-5","volume":"12","author":"M Manouchehri","year":"2022","unstructured":"Manouchehri M, Cea-Soriano L, Franch-Nadal J, Ruiz A, Goday A, Villanueva R, et al. Heterogeneity in the association between prediabetes categories and reduction on glomerular filtration rate in a 5-year follow-up. Sci Rep. 2022;12(1):7373.","journal-title":"Sci Rep"},{"issue":"1","key":"5212_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target therapy. 2023;8(1):152.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"5212_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000479801","volume":"8","author":"A Whaley-Connell","year":"2017","unstructured":"Whaley-Connell A, Sowers JR. Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity. Cardiorenal Med. 2017;8(1):41\u20139.","journal-title":"Cardiorenal Med"},{"issue":"2","key":"5212_CR49","first-page":"19","volume":"26","author":"G Wilcox","year":"2005","unstructured":"Wilcox G. Insulin and insulin resistance. Clin biochemist reviews. 2005;26(2):19.","journal-title":"Clin biochemist reviews"},{"key":"5212_CR50","doi-asserted-by":"crossref","unstructured":"Kumar M, Dev S, Khalid MU, Siddenthi SM, Noman M, John C et al. The bidirectional link between diabetes and kidney disease: mechanisms and management. Cureus. 2023;15(9).","DOI":"10.7759\/cureus.45615"},{"key":"5212_CR51","volume-title":"Diabetic nephropathy (nursing)","author":"P Rout","year":"2025","unstructured":"Rout P, Jialal I, Doerr C. Diabetic nephropathy (nursing). StatPearls [Internet]: StatPearls Publishing; 2025."},{"issue":"9","key":"5212_CR52","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/jcm8091385","volume":"8","author":"E Burgos-Mor\u00f3n","year":"2019","unstructured":"Burgos-Mor\u00f3n E, Abad-Jim\u00e9nez Z, Martinez de Maranon A, Iannantuoni F, Escribano-L\u00f3pez I, L\u00f3pez-Dom\u00e8nech S, et al. Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues. J Clin Med. 2019;8(9):1385.","journal-title":"J Clin Med"},{"issue":"8","key":"5212_CR53","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.3390\/cimb45080420","volume":"45","author":"A Caturano","year":"2023","unstructured":"Caturano A, D\u2019Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, et al. Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023;45(8):6651\u201366.","journal-title":"Curr Issues Mol Biol"},{"key":"5212_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","volume":"184","author":"JS Bhatti","year":"2022","unstructured":"Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022;184:114\u201334.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"5212_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/jrms.JRMS_472_18","volume":"25","author":"MH Alijanvand","year":"2020","unstructured":"Alijanvand MH, Aminorroaya A, Kazemi I, Amini M, Yamini SA, Mansourian M. Prevalence and predictors of prediabetes and its coexistence with high blood pressure in first-degree relatives of patients with type 2 diabetes: a 9-year cohort study. J Res Med Sci. 2020;25(1):31.","journal-title":"J Res Med Sci"},{"issue":"4","key":"5212_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","volume":"79","author":"D Pugh","year":"2019","unstructured":"Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019;79(4):365\u201379.","journal-title":"Drugs"},{"key":"5212_CR57","doi-asserted-by":"publisher","first-page":"949260","DOI":"10.3389\/fphar.2022.949260","volume":"13","author":"OZ Ameer","year":"2022","unstructured":"Ameer OZ. Hypertension in chronic kidney disease: What lies behind the scene. Front Pharmacol. 2022;13:949260.","journal-title":"Front Pharmacol"},{"key":"5212_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-016-0303-x","volume":"17","author":"SL Seliger","year":"2016","unstructured":"Seliger SL, Salimi S, Pierre V, Giffuni J, Katzel L, Parsa A. Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults. BMC Nephrol. 2016;17:1\u20138.","journal-title":"BMC Nephrol"},{"key":"5212_CR59","doi-asserted-by":"crossref","unstructured":"Cheng H, Harris C. R. Renal endothelial dysfunction in diabetic nephropathy. Cardiovas Haematolo Disord Drug Targets (Formerly Current Drug Targets-Cardiovas Hematol Disord). 2014;14(1):22\u201333.","DOI":"10.2174\/1871529X14666140401110841"},{"issue":"3","key":"5212_CR60","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/life13030644","volume":"13","author":"S Lamprou","year":"2023","unstructured":"Lamprou S, Koletsos N, Mintziori G, Anyfanti P, Trakatelli C, Kotsis V, et al. Microvascular and endothelial dysfunction in prediabetes. Life. 2023;13(3):644.","journal-title":"Life"},{"issue":"4","key":"5212_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1751-7176.2011.00449.x","volume":"13","author":"WA Hsueh","year":"2011","unstructured":"Hsueh WA, Wyne K. Renin-angiotensin\u2010aldosterone system in diabetes and hypertension. J Clin Hypertens. 2011;13(4):224\u201337.","journal-title":"J Clin Hypertens"},{"issue":"6","key":"5212_CR62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","volume":"31","author":"HM Siragy","year":"2010","unstructured":"Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010;31(6):541\u201350.","journal-title":"Am J Nephrol"},{"issue":"6","key":"5212_CR63","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/ehf2.12516","volume":"6","author":"K Nochioka","year":"2019","unstructured":"Nochioka K, Sakata Y, Miura M, Shiroto T, Takahashi J, Saga C, et al. Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial. ESC Heart Fail. 2019;6(6):1252\u201361.","journal-title":"ESC Heart Fail"},{"issue":"3","key":"5212_CR64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.numecd.2017.12.005","volume":"28","author":"MRP Markus","year":"2018","unstructured":"Markus MRP, Ittermann T, Baumeister SE, Huth C, Thorand B, Herder C, et al. Prediabetes is associated with microalbuminuria, reduced kidney function and chronic kidney disease in the general population: The KORA (Cooperative Health Research in the Augsburg Region) F4-Study. Nutr Metabolism Cardiovasc Dis. 2018;28(3):234\u201342.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"5212_CR65","doi-asserted-by":"crossref","unstructured":"Plantinga P LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010;5(4):673\u201382.","DOI":"10.2215\/CJN.07891109"},{"key":"5212_CR66","doi-asserted-by":"crossref","unstructured":"Li W, Wang AP, Jiang JJ, Liu GX, Wang MP, Li DX, et al. Risk of chronic kidney disease defined by decreased estimated glomerular filtration rate in individuals with different prediabetic phenotypes: results from a prospective cohort study in China. BMJ Open Diabetes Res Care. 2020;8(1).","DOI":"10.1136\/bmjdrc-2019-000955"},{"key":"5212_CR67","doi-asserted-by":"crossref","unstructured":"Kim GS, Oh HH, Kim SH, Kim BO, Byun YS. Association between prediabetes (defined by HbA1 C, fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: A 9-year prospective cohort study. BMC Nephrol. 2019;20(1).","DOI":"10.1186\/s12882-019-1307-0"},{"issue":"4","key":"5212_CR68","doi-asserted-by":"publisher","first-page":"E1772","DOI":"10.1210\/clinem\/dgaa017","volume":"105","author":"JS Neves","year":"2020","unstructured":"Neves JS, Correa S, Baptista RB, Vieira MB, Waikar SS, Mc Causland FR. Association of prediabetes with ckd progression and adverse cardiovascular outcomes: An analysis of the cric study. J Clin Endocrinol Metab. 2020;105(4):E1772\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"5212_CR69","doi-asserted-by":"crossref","unstructured":"Vieira MB, Neves JS, Leitao L, Baptista RB, Magri\u00e7o R, Dias CV et al. Impaired fasting glucose and chronic kidney disease, albuminuria, or worsening kidney function: a secondary analysis of SPRINT. J Clin Endocrinol Metabol. 2019;104(9):4024-32.","DOI":"10.1210\/jc.2019-00073"},{"issue":"11","key":"5212_CR70","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/ckj\/sfab074","volume":"14","author":"MA Schroijen","year":"2021","unstructured":"Schroijen MA, De Mutsert R, Dekker FW, De Vries APJ, De Koning EJP, Rabelink TJ, et al. The association of glucose metabolism and kidney function in middle-aged adults. Clin Kidney J. 2021;14(11):2383\u201390.","journal-title":"Clin Kidney J"},{"issue":"10","key":"5212_CR71","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.2337\/diacare.28.10.2436","volume":"28","author":"CS Fox","year":"2005","unstructured":"Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PWF, Levy D. Glycemic status and development of kidney disease - The Framingham Heart Study. Diabetes Care. 2005;28(10):2436\u201340.","journal-title":"Diabetes Care"},{"issue":"11","key":"5212_CR72","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.2337\/dc18-0718","volume":"41","author":"A Tsuda","year":"2018","unstructured":"Tsuda A, Ishimura E, Uedono H, Ochi A, Nakatani S, Morioka T, et al. Association of albuminuria with intraglomerular hydrostatic pressure and insulin resistance in subjects with impaired fasting glucose and\/or impaired glucose tolerance. Diabetes Care. 2018;41(11):2414\u201320.","journal-title":"Diabetes Care"},{"issue":"5","key":"5212_CR73","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s40620-018-0524-0","volume":"31","author":"A Rodriguez-Poncelas","year":"2018","unstructured":"Rodriguez-Poncelas A, Coll-de-Tuero G, Blanch J, Comas-Cuf\u00ed M, Saez M, Barcel\u00f3 MA. Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study. J Nephrol. 2018;31(5):743\u20139.","journal-title":"J Nephrol"},{"issue":"11","key":"5212_CR74","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00592-021-01759-x","volume":"58","author":"C Bian","year":"2021","unstructured":"Bian C, Gao J, Wang Y, Li J, Luan Z, Lu H, et al. Association of SIRT6 circulating levels with urinary and glycometabolic markers in pre-diabetes and diabetes. Acta Diabetol. 2021;58(11):1551\u201362.","journal-title":"Acta Diabetol"},{"key":"5212_CR75","doi-asserted-by":"crossref","unstructured":"Choi JW, Oh IH, Lee CH, Park JS. Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population. PLoS ONE. 2017;12(7).","DOI":"10.1371\/journal.pone.0180924"},{"key":"5212_CR76","doi-asserted-by":"crossref","unstructured":"Furukawa M, Onoue T, Kato K, Wada T, Shinohara Y, Kinoshita F et al. Prediabetes is associated with proteinuria development but not with glomerular filtration rate decline: A longitudinal observational study. Diabet Med. 2021;38(8).","DOI":"10.1111\/dme.14607"},{"key":"5212_CR77","doi-asserted-by":"crossref","unstructured":"Ganesh V, Murugan M, Palem SP. Adiponectin can be an early predictable marker for type 2 diabetes mellitus and nephropathy. Cureus J Med Sci. 2022;14(7).","DOI":"10.7759\/cureus.27308"},{"issue":"8","key":"5212_CR78","doi-asserted-by":"publisher","first-page":"435","DOI":"10.11622\/smedj.2019052","volume":"61","author":"HE Sumbul","year":"2020","unstructured":"Sumbul HE, Koc AS, G\u00fcl\u00fcmsek E. Renal cortical stiffness is markedly increased in pre-diabetes mellitus and associated with albuminuria. Singapore Med J. 2020;61(8):435\u201342.","journal-title":"Singapore Med J"},{"key":"5212_CR79","doi-asserted-by":"crossref","unstructured":"Notohamiprodjo M, Goepfert M, Will S, Lorbeer R, Schick F, Rathmann W et al. Renal and renal sinus fat volumes as quantified by magnetic resonance imaging in subjects with prediabetes, diabetes, and normal glucose tolerance. PLoS ONE. 2020;15(2).","DOI":"10.1371\/journal.pone.0216635"},{"key":"5212_CR80","doi-asserted-by":"crossref","unstructured":"Zivkovic M, T\u00f6njes A, Baber R, Wirkner K, Loeffler M, Engel C. Prevalence of moderately increased albuminuria among individuals with normal HbA1c level but impaired glucose tolerance: Results from the LIFE-adult-study. Endocrinol Diabetes Metabol. 2018;1(4).","DOI":"10.1002\/edm2.30"},{"issue":"12","key":"5212_CR81","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/ajh\/hpz105","volume":"32","author":"N Rathi","year":"2019","unstructured":"Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, et al. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events. Am J Hypertens. 2019;32(12):1170\u20137.","journal-title":"Am J Hypertens"},{"key":"5212_CR82","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2147\/DMSO.S250347","volume":"13","author":"J Ning","year":"2020","unstructured":"Ning J, Xiang Z, Xiong C, Zhou Q, Wang X, Zou H. Alpha1-antitrypsin in urinary extracellular vesicles: A potential biomarker of diabetic kidney disease prior to microalbuminuria. Diabetes Metabolic Syndrome Obes. 2020;13:2037\u201348.","journal-title":"Diabetes Metabolic Syndrome Obes"},{"issue":"10","key":"5212_CR83","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jdiacomp.2017.07.002","volume":"31","author":"SH Min","year":"2017","unstructured":"Min SH, Kong SH, Lee JE, Lee DH, Oh TJ, Kim KM, et al. Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus. J Diabetes Complicat. 2017;31(10):1499\u2013505.","journal-title":"J Diabetes Complicat"},{"key":"5212_CR84","doi-asserted-by":"crossref","unstructured":"Zheng X, Liu Q, Liu Z. Serum homocysteine concentration as a marker for advanced diabetic nephropathy in a cohort of elderly patients. BMC Endocr Disorders. 2023;23(1).","DOI":"10.1186\/s12902-023-01342-1"},{"key":"5212_CR85","doi-asserted-by":"crossref","unstructured":"Parmar D, Bhattacharya N, Kannan S, Vadivel S, Pandey GK, Ghanate A et al. Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy. Sci Rep. 2020;10(1).","DOI":"10.1038\/s41598-020-59897-1"},{"issue":"7","key":"5212_CR86","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2337\/dc11-0235","volume":"34","author":"T Melsom","year":"2011","unstructured":"Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njolstad I, Solbu MD, et al. Impaired Fasting Glucose Is Associated With Renal Hyperfiltration in the General Population. Diabetes Care. 2011;34(7):1546\u201351.","journal-title":"Diabetes Care"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05212-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:02:23Z","timestamp":1792641743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05212-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5212"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05212-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of Isfahan University of Medical Sciences approved this study. The ethics approval code is: IR.MUI.RESEARCH.REC.1400.251.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"624"}}